These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11377570)

  • 1. Pharmacokinetics of tacrolimus during the early phase after heart transplantation.
    Molinaro M; Regazzi MB; Pasquino S; Rinaldi M; Iacona I; Campana C; Viganò M
    Transplant Proc; 2001 May; 33(3):2386-9. PubMed ID: 11377570
    [No Abstract]   [Full Text] [Related]  

  • 2. Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients.
    Marcus N; Khaghani A; Burke M; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1134-5. PubMed ID: 9636460
    [No Abstract]   [Full Text] [Related]  

  • 3. Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
    Pham SM; Kormos RL; Kawai A; Murali S; Hattler BG; Demetris AJ; Griffith BP
    Transplant Proc; 1996 Apr; 28(2):1002-4. PubMed ID: 8623208
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel tacrolimus dosing strategy in cardiac transplantation: drug levels, renal function, and biopsy results.
    Baran DA; Galin ID; Sandler D; Segura L; Correa R; Courtney MC; Cheng J; Chan M; Lansman SL; Spielvogel D; Fallon JT; Gass AL
    Transplant Proc; 2002 Aug; 34(5):1834-5. PubMed ID: 12176595
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.
    Teebken OE; Strüber M; Harringer W; Pichlmaier MA; Haverich A
    Transplant Proc; 2002 Jun; 34(4):1265-8. PubMed ID: 12072335
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical pharmacokinetics of tacrolimus in heart transplantation: new strategies of monitoring.
    Aumente Rubio MD; Arizón del Prado JM; López Malo de Molina MD; Cárdenas Aranzana M; Segura Saint-Gerons J; López Granados A; Rodriguez Esteban E; Mesa Rubio D; Romo Peñas E; Segura Saint-Gerons C
    Transplant Proc; 2003 Aug; 35(5):1988-91. PubMed ID: 12962871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical influencing factors for daily dose, trough level, and relative clearance of tacrolimus in renal transplant recipients.
    Hu RH; Lee PH; Tsai MK
    Transplant Proc; 2000 Nov; 32(7):1689-92. PubMed ID: 11119894
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective study of a tacrolimus-based quadruple immunosuppressive regimen: evaluation of safety and efficacy.
    Lladó L; Figueras J; Ramos E; Baliellas C; Torras J; Rafecas A; Fabregat J; Lama C; Ibañez L; Jaurrieta E
    Transplant Proc; 2002 Aug; 34(5):1526-8. PubMed ID: 12176468
    [No Abstract]   [Full Text] [Related]  

  • 9. Pretransplant pharmacokinetics: does it predict the dose of tacrolimus after renal transplantation?
    Boots JM; Christiaans MH; Undre NA; van Hooff JP
    Transplant Proc; 2002 Dec; 34(8):3171-2. PubMed ID: 12493409
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group.
    Undre NA; Schäfer A
    Transplant Proc; 1998 Jun; 30(4):1261-3. PubMed ID: 9636512
    [No Abstract]   [Full Text] [Related]  

  • 11. Initial experience of combined immunosuppressive induction therapy with polyclonal antithymocyte antibody, FK 506 (tacrolimus), and prednisolone in clinical liver transplantation.
    Fischer S; Hopkinson D; Cassivi SD; Saad S; Paul A
    Transplant Proc; 2000 Dec; 32(8):2817-9. PubMed ID: 11134815
    [No Abstract]   [Full Text] [Related]  

  • 12. Tacrolimus pharmacokinetics in heart transplant.
    Sgrosso JL; Araujo GL; Vázquez MC
    Transplant Proc; 2002 Feb; 34(1):142-3. PubMed ID: 11959225
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients.
    Hesse CJ; Baan CC; Balk AH; Metselaar HJ; Weimar W; van Gelder T
    Transplant Proc; 2002 Nov; 34(7):2988-90. PubMed ID: 12431679
    [No Abstract]   [Full Text] [Related]  

  • 14. Implication of HLA mismatch in the clinical outcome of orthotopic heart transplantation.
    Aziz TM; Sheldon S; el-Gamel A; Krysiak P; Campbell C; Rahman A; Dyer P; Yonan N; Deiraniya A
    Transplant Proc; 1998 Aug; 30(5):1917-9. PubMed ID: 9723332
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of cyclosporine monitoring with trough levels to levels obtained 6 hours after the morning dose in heart transplant patients: a prospective randomized study.
    Cantarovich M; Latter D; Fitchett D
    Transplant Proc; 1997; 29(1-2):602-4. PubMed ID: 9123149
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective evaluation of a quadruple therapy based on tacrolimus after liver transplantation.
    Lladó L; Figueras J; Ramos E; Lama C; Busquets J; Ibáñez L; Rafecas A; Fabregat J; Torras J; Jaurrieta E
    Transplant Proc; 2002 Feb; 34(1):108. PubMed ID: 11959210
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic drug monitoring of tacrolimus in cardiac transplant recipients: a comparison with cyclosporine neoral.
    Wang CH; Ko WJ; Chou NK; Wang SS
    Transplant Proc; 2004 Oct; 36(8):2386-7. PubMed ID: 15561257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus vs CyA Neoral in combination with MMF and steroids after cadaveric renal transplantation.
    Wang XH; Tang XD; Xu D
    Transplant Proc; 2000 Nov; 32(7):1702-3. PubMed ID: 11119899
    [No Abstract]   [Full Text] [Related]  

  • 19. Multicenter evaluation of immunosuppressive regimens in heart transplantation. The Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1997; 29(1-2):617-9. PubMed ID: 9123156
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.
    Chen YH; Zheng KL; Chen LZ; Dai YP; Fei JG; Qiu J; Li J
    Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.